CUX1 and neoplasm: In an initial approach to determine whether tumor suppressor loss could induce adaptive cellular responses vital for survival, we performed genome-wide CRISPR/Cas9 drop-out screens in isogenic myeloid cancer cells that differed solely in CUX1 status (Fig. 1a).